Europe Healthcare Reimbursement Market Size, Share & Trends Analysis Report By Claim (Underpaid and Full Paid), By Service Provider, By Payer (Public Payers and Private Payers), By Country and Growth Forecast, 2024 - 2031

The Europe Healthcare Reimbursement Market would witness market growth of 17.1% CAGR during the forecast period (2024-2031).

The Germany market dominated the Europe Healthcare Reimbursement Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $3,930.5 Million by 2031. The UK market is exhibiting a CAGR of 16.1% during (2024 - 2031). Additionally, The France market would experience a CAGR of 18% during (2024 - 2031).

The market finds applications across multiple domains in the healthcare industry. Reimbursement systems cover services provided in hospitals, clinics, and other healthcare facilities. These include inpatient stays, outpatient procedures, diagnostic tests, and follow-up care. Insurance providers compensate healthcare organizations based on pre-established codes and fee schedules for these services.

Public and private insurance providers reimburse prescription drugs, vaccines, and medical devices such as pacemakers, insulin pumps, and diagnostic imaging equipment. The growing burden of chronic diseases has increased the demand for drug reimbursement plans to reduce patients' financial burden. Reimbursement plans increasingly cover preventive healthcare services such as screenings, vaccinations, and wellness programs. Governments and private insurers are focusing on incentivizing preventive care to reduce healthcare costs in the long term.

Italy’s healthcare sector is undergoing digital transformation, with ICT expenditures reaching $1.98 billion in 2022, a 7% increase from 2021. The government’s focus on modernizing the healthcare system through the National Recovery and Resilience Program (NRRP) is accelerating the adoption of digital health technologies. The allocation of €1.67 billion for EMR and e-health infrastructure is expected to streamline patient data management and improve claims accuracy, reducing reimbursement delays and errors.

The growing adoption of telemedicine, digital diagnostics, and connected health devices will generate a larger volume of complex reimbursement claims, necessitating advanced systems capable of seamlessly processing and integrating these claims. As Italy continues to invest in digital health, there is potential for increased collaboration within the European Union for cross-border healthcare services, creating further opportunities for the reimbursement market. In conclusion, the rising healthcare expenditure in the UK and the growing investment in ICT and e-health technologies in Italy are accelerating the market's growth.

Based on Claim, the market is segmented into Underpaid and Full Paid. Based on Service Provider, the market is segmented into Hospitals, Diagnostic Laboratories, Physician Office, and Other Service Provider. Based on Payer, the market is segmented into Public Payers and Private Payers. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

List of Key Companies Profiled

• United HealthCare Services, Inc.
• Allianz Care (Allianz Group)
• CVS Health Corporation (ActiveHealth Management, Inc.)
• Nippon Life Insurance Company Limited
• The Cigna Group
• Elevance Health, Inc.
• Humana Inc.
• Molina Healthcare, Inc.
• Centene Corporation
• MetLife, Inc.

Europe Healthcare Reimbursement Market Report Segmentation

By Claim

• Underpaid
• Full Paid

By Service Provider

• Hospitals
• Diagnostic Laboratories
• Physician Office
• Other Service Provider

By Payer

• Public Payers
• Private Payers

By Country

• Germany
• UK
• France
• Russia
• Spain
• Italy
• Rest of Europe